Revvity stock trades around $123 as investors weigh latest earnings and analyst targets
Published on 08/21/2026 at 19:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revvity Inc. (US76155R1086) stock is quoted at $123.25 on the New York Stock Exchange as of August 21, 2026, with the shares up 27.3% from a 52-week low of $96.80 earlier in the year.
Stock performance and valuation context
According to market data compiled in the latest stock overview, Revvity stock is trading at $123.25 in intraday action on August 21, 2026, reflecting a modest decline of 0.71% on the day from a prior close of $124.13.
The same overview highlights that since hitting a 52-week low of $96.80, Revvity stock has gained 27.3%, underscoring how the share price has recovered even though the current level remains above the average analyst target of $108.36.
Analyst view and recent flows
Recent ownership disclosures show institutional investors increasing their exposure to Revvity, with one filing citing a purchase of 43,063 shares and another noting a larger position of 148,853 shares, both aligned with a consensus analyst stance that rates the shares as a hold and points to an average price target of $108.36.
The gap between the $123.25 trading level and the $108.36 consensus target means the stock is trading 13.7% above the average analytical expectation, an important consideration for valuation-focused investors who weigh upside against earnings momentum.
Business profile and product focus
Revvity Inc. develops and markets analytical instruments and measurement devices for healthcare, environmental monitoring, scientific research, industrial applications, and food safety, providing hardware and related solutions that help laboratories and enterprises generate and interpret data.
Within its portfolio, a representative product line is its integrated analytical platforms used in clinical and research laboratories, which combine automated sample handling with detection technologies to support diagnostics workflows and high-throughput testing.
Revvity stock and market snapshot
Revvity stock, listed under the ticker RVTY on the New York Stock Exchange, continues to trade in the low-$120s as of August 21, 2026, with the current quote of $123.25 standing above the $108.36 consensus target and well above the 52-week low of $96.80, highlighting a share price that has already priced in a degree of optimism about future earnings.
Fact box
Company: Revvity Inc.
ISIN: US76155R1086
Ticker: RVTY
Exchange: NYSE
Price (as of August 21, 2026, 11:05 a.m. ET): $123.25 USD
Sector / Industry: Health care equipment and analytical instruments
Index membership: S&P 500
